HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ondřej Vaněk Selected Research

Ondřej Vaněk Research Topics

Disease

9Neoplasms (Cancer)
05/2023 - 09/2011
2Infections
01/2022 - 01/2015
1Carcinoma (Carcinomatosis)
10/2011
1Hypertension (High Blood Pressure)
09/2011

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2020
2LigandsIBA
10/2011 - 09/2011
1Interleukin-2 (IL2)IBA
05/2023
1CytokinesIBA
05/2023
1GlycoconjugatesIBA
01/2022
1NK Cell Lectin-Like Receptor Subfamily BIBA
01/2022
1Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
01/2022
1C-Type Lectins (C-Type Lectin)IBA
01/2022
1VaccinesIBA
01/2022
1Granzymes (Granzyme)IBA
11/2021
1Fas Ligand Protein (Fas Ligand)IBA
11/2021
1Biopolymers (Biopolymer)IBA
11/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1EpitopesIBA
01/2021
1N-(2-hydroxypropyl)methacrylamideIBA
01/2020
1Oxaloacetic Acid (Oxalacetic Acid)IBA
01/2015
1Pyruvic Acid (Pyruvate)IBA
01/2015
1EnzymesIBA
01/2015
1CarbonIBA
01/2015
1PhosphoenolpyruvateIBA
01/2015
1Immunoglobulin FragmentsIBA
10/2011
1Carbonic Anhydrase IXIBA
10/2011

Therapy/Procedure

2Immunotherapy
01/2022 - 11/2021
2Therapeutics
01/2021 - 01/2020